Vikram Thermo India [VIKRAMTH] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Vikram Thermo India wins in 10 metrics, Sun Pharmaceutical wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

MetricVikram Thermo IndiaSun PharmaceuticalBetter
P/E Ratio (TTM)15.8437.73Vikram Thermo India
Price-to-Book Ratio4.305.42Vikram Thermo India
Debt-to-Equity Ratio5.273.26Sun Pharmaceutical
PEG Ratio-0.11-1.94Sun Pharmaceutical
EV/EBITDA11.9523.98Vikram Thermo India
Profit Margin (TTM)25.77%19.29%Vikram Thermo India
Operating Margin (TTM)37.09%24.34%Vikram Thermo India
EBITDA Margin (TTM)37.09%24.34%Vikram Thermo India
Return on Equity6.67%15.08%Sun Pharmaceutical
Return on Assets (TTM)5.55%11.87%Sun Pharmaceutical
Free Cash Flow (TTM)$-171.83M$119.44BSun Pharmaceutical
Dividend Yield1.03%1.26%Sun Pharmaceutical
1-Year Return-3.14%-14.60%Vikram Thermo India
Price-to-Sales Ratio (TTM)4.227.28Vikram Thermo India
Enterprise Value$5.29B$3,678.87BSun Pharmaceutical
EV/Revenue Ratio4.286.84Vikram Thermo India
Gross Profit Margin (TTM)66.18%79.58%Sun Pharmaceutical
Revenue per Share (TTM)$39$224Sun Pharmaceutical
Earnings per Share (Diluted)$10.52$43.23Sun Pharmaceutical
Beta (Stock Volatility)-0.320.28Vikram Thermo India
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Vikram Thermo India vs Sun Pharmaceutical Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Vikram Thermo India-0.87%2.36%1.85%7.10%-7.19%-5.44%
Sun Pharmaceutical-0.31%2.80%3.33%-2.89%-7.84%-13.69%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Vikram Thermo India-3.14%205.27%-16.57%140.57%551.48%307.27%
Sun Pharmaceutical-14.60%70.78%218.03%80.00%690.16%2,608.73%

News Based Sentiment: Vikram Thermo India vs Sun Pharmaceutical

Vikram Thermo India

News based Sentiment: MIXED

September presented a mixed bag for Vikram Thermo, with a notable profit turnaround offsetting a revenue decline. The AGM and subsequent management changes, coupled with shifts in shareholding, add complexity to the investment picture. While the company's financial health appears strong, the fluctuating share price and evolving leadership warrant careful monitoring.

View Vikram Thermo India News Sentiment Analysis

Sun Pharmaceutical

News based Sentiment: MIXED

October was a mixed month for Sun Pharma, with a significant acquisition balanced against a decline in net profit. Positive analyst ratings and tariff news provide offsetting positive signals, making it a month of notable, but not overwhelmingly positive, developments for investors.

View Sun Pharmaceutical News Sentiment Analysis

Performance & Financial Health Analysis: Vikram Thermo India vs Sun Pharmaceutical

MetricVIKRAMTHSUNPHARMA
Market Information
Market Cap i₹5.35B₹4.01T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i6,8143,168,435
90 Day Avg. Volume i11,4242,778,768
Last Close₹165.15₹1,631.20
52 Week Range₹126.85 - ₹216.45₹1,548.00 - ₹1,952.25
% from 52W High-23.70%-16.45%
All-Time High₹311.00 (Apr 25, 2022)₹1,960.35 (Sep 30, 2024)
% from All-Time High-46.90%-16.79%
Growth Metrics
Quarterly Revenue Growth-0.08%0.10%
Quarterly Earnings Growth-0.08%-0.20%
Financial Health
Profit Margin (TTM) i0.26%0.19%
Operating Margin (TTM) i0.37%0.24%
Return on Equity (TTM) i0.07%0.15%
Debt to Equity (MRQ) i5.273.26
Cash & Liquidity
Book Value per Share (MRQ)₹38.75₹300.99
Cash per Share (MRQ)₹0.17₹108.88
Operating Cash Flow (TTM) i₹325.14M₹110.84B
Levered Free Cash Flow (TTM) i₹80.99M₹109.29B
Dividends
Last 12-Month Dividend Yield i1.03%1.26%
Last 12-Month Dividend i₹1.75₹21.00

Valuation & Enterprise Metrics Analysis: Vikram Thermo India vs Sun Pharmaceutical

MetricVIKRAMTHSUNPHARMA
Price Ratios
P/E Ratio (TTM) i15.8437.73
Forward P/E iN/A49.91
PEG Ratio i-0.11-1.94
Price to Sales (TTM) i4.227.28
Price to Book (MRQ) i4.305.42
Market Capitalization
Market Capitalization i₹5.35B₹4.01T
Enterprise Value i₹5.29B₹3.68T
Enterprise Value Metrics
Enterprise to Revenue i4.286.84
Enterprise to EBITDA i11.9523.98
Risk & Other Metrics
Beta i-0.320.28
Book Value per Share (MRQ) i₹38.75₹300.99

Financial Statements Comparison: Vikram Thermo India vs Sun Pharmaceutical

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)VIKRAMTHSUNPHARMA
Revenue/Sales i₹286.05M₹137.86B
Cost of Goods Sold i₹96.75M₹28.15B
Gross Profit i₹189.30M₹109.71B
Research & Development iN/AN/A
Operating Income (EBIT) i₹106.08M₹33.72B
EBITDA i₹114.82M₹47.66B
Pre-Tax Income i₹106.57M₹31.73B
Income Tax i₹27.15M₹8.70B
Net Income (Profit) i₹79.41M₹22.93B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)VIKRAMTHSUNPHARMA
Cash & Equivalents i₹1.62M₹102.69B
Total Current Assets i₹627.63M₹526.24B
Total Current Liabilities i₹200.68M₹181.94B
Long-Term Debt i₹21.88M₹3.58B
Total Shareholders Equity i₹1.21B₹724.86B
Retained Earnings i₹806.21M₹578.62B
Property, Plant & Equipment i₹27.49M₹100.36B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)VIKRAMTHSUNPHARMA
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricVIKRAMTHSUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i6,8143,168,435
Average Daily Volume (90 Day) i11,4242,778,768
Shares Outstanding i31.36M2.40B
Float Shares i9.25M1.06B
% Held by Insiders i0.68%0.56%
% Held by Institutions i0.00%0.25%

Dividend Analysis & Yield Comparison: Vikram Thermo India vs Sun Pharmaceutical

MetricVIKRAMTHSUNPHARMA
Last 12-Month Dividend i₹1.75₹21.00
Last 12-Month Dividend Yield i1.03%1.26%
3-Year Avg Annual Dividend i₹0.75₹14.67
3-Year Avg Dividend Yield i0.50%0.46%
3-Year Total Dividends i₹2.25₹44.00
Ex-Dividend DateSep 19, 2025Jul 07, 2025